Gene Therapy and Radioactive Iodine in Treating Patients With Locally Recurrent Prostate Cancer That Did Not Respond to External-Beam Radiation Therapy

NCT00788307 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

8

Enrollment

OTHER

Sponsor class

Stopped closed early due to poor accrual

Conditions

Prostate Cancer

Interventions

BIOLOGICAL: Ad5-CMV-NIS
DRUG: liothyronine sodium
GENETIC: reverse transcriptase-polymerase chain reaction
OTHER: laboratory biomarker analysis
RADIATION: iodine I 131

Sponsor

Mayo Clinic

Collaborators

[object Object]